Plesner advised Zealand Pharma on the deal. NASDAQ Copenhagen-listed biotech Zealand Pharma, signed a finance contract agreement with The European Investment Bank concerning a EUR 90 million term...
This content is for Standard 1 Year members only. LoginJoin Now